0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°£È£»çÀÇ Ç×¾ÏÁ¦ ¾ÈÀü°ü¸®Áöħ ¼öÇ൵, ³ëÃâ·Î ÀÎÇÑ ÀÚ°¢Áõ»ó ¹× ½ºÆ®·¹½ºÀÇ °ü°è

Nurses¡¯ Compliance with Safety Guidelines for the Use of Antineoplastic Agents, Observable Symptoms, and Stress from Occupational Exposure

±âº»°£È£ÇÐȸÁö 2018³â 25±Ç 4È£ p.293 ~ 300
KMID : 0388320180250040293
¹Ú¼±ÀÚ ( Park Seon-Ja ) - µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø

±èÇöÁÖ ( Kim Hyun-Ju ) - ºÎ»ê°¡Å縯´ëÇб³ °£È£´ëÇÐ

Abstract

Purpose: This study was done to identify the relationship between nurses¡¯ compliance with safety guidelines for the use of antineoplastic agents, observable symptoms, and stress from occupational exposure.

Methods: The participants were 172 nurses from six general hospitals in a metropolitan area. They had administered antineoplastic agents at least three months prior to the study. Data were collected using self-report questionnaires, and then analyzed using SPSS/WIN 23.0 for descriptive statistics, t-test, one-way ANOVA, Scheffe? method, and Pearson correlation coefficient.

Results: The average score on the guideline for safety compliance was 87.75 points out of a total of 100. The average score for observable symptoms of exposure to antineoplastic agents was 30.12 (28~56) points, and that for mean stress was 33.52 (15~60) points. Observable symptoms and stress from occupational exposure showed a statistically significant positive correlation (r=0.34, p<.001).

Conclusion: To increase the degree of compliance with safety guidelines for antineoplastic agents, hospitals should lower the chance of exposure to antineoplastic agents, as well as minimize the observable symptoms and stress from occupational exposure. Periodic education and policy support are needed to improve compliance with safety guidelines for antineoplastic agent use.
KeyWords
Ç×¾ÏÁ¦, ¾ÈÀü°ü¸®, ÀÌÇà, ÀÚ°¢Áõ»ó, ½ºÆ®·¹½º
Antineoplastic agents, Safety, Compliance, Symptoms, Stress
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed